Patient-derived organoids may help personalize the treatment of gastrointestinal cancers

January 17, 2018, Wiley

A new BJS (British Journal of Surgery) review highlights the potential of 3D organoid models derived from patient cells to help personalize therapy for individuals with gastrointestinal cancers.

Organoids—artificially grown masses of cells or tissues that resemble organs—are being used by researchers in a range of biomedical fields as they study various disease states and work to develop potential treatments. Organoid culture methods have been established for healthy and diseased tissues from oesophagus, stomach, intestine, pancreas, , and liver. Because organoids can be generated with high efficiency and speed from patient samples, they can serve as a personal model that can guide clinical decision-making.

"Research using organoids has already unraveled so many of the underlying causes of cancer. But, for me, their real promise lies in their capacity to predict response," said lead author Merel Aberle, MD, of Maastricht University, in The Netherlands. "In future, organoids could be used to find the best treatment combination for every patient, thereby increasing response rates, but also reducing the side-effects unnecessary treatment may cause. I hope that this review inspires more surgeons, oncologists, radiologists, and other healthcare professionals to use this model and set up collaborative clinical trials."

Explore further: 3-D pancreatic cancer organoid may help predict clinical responses, personalize treatments

More information: M. R. Aberle et al, Patient-derived organoid models help define personalized management of gastrointestinal cancer, British Journal of Surgery (2018). DOI: 10.1002/bjs.10726

Related Stories

3-D pancreatic cancer organoid may help predict clinical responses, personalize treatments

October 27, 2015
The development of a new method to grow three-dimensional organoid cultures of pancreatic tumors directly from patients' surgical tissue offers a promising opportunity for testing targeted therapies and drug responses and ...

Modular approach found to improve consistency of organoids

August 15, 2017
(Medical Xpress)—A team of researchers from the U.S. and Australia working at the Yale Stem Cell Center report that they have met with some success in improving the usefulness of organoids. In their paper published in the ...

Hairy skin grown from mouse stem cells

January 2, 2018
Indiana University School of Medicine researchers have cultured the first lab-grown skin tissue complete with hair follicles. This skin model, developed using stem cells from mice, more closely resembles natural hair than ...

The newest precision medicine tool: Prostate cancer organoids

September 4, 2014
Research led by investigators at Memorial Sloan Kettering Cancer Center has shown for the first time that organoids derived from human prostate cancer tumors can be grown in the laboratory, giving researchers an exciting ...

New technologies combined to identify specific DNA defect underlying a type of cancer

September 15, 2017
(Medical Xpress)—A team of researchers from the Netherlands and the U.K. has developed a technique for studying inherited types of cancers using two relatively new technologies—organoid development and CRISPR/Cas9. In ...

Researchers create unique bioengineered organoids for modeling colorectal cancer

December 5, 2017
A new study describes a unique bioengineered tissue construct, or organoid, into which colorectal cancer cells are embedded, creating a model of the tumor and surrounding extracellular matrix (ECM). Researchers can use this ...

Recommended for you

Surgical adhesions can be treated, prevented in mice

November 28, 2018
A cellular culprit—as well as a possible treatment—for a common, sometimes life-threating post-surgical complication has been identified by researchers at the Stanford University School of Medicine.

Cost and weight-loss potential matter most to bariatric surgery patients

November 28, 2018
A JAMA Surgery study found that patients are likely to base their weight loss surgery choice on expected out-of-pocket costs, and how much weight they can lose—not risk of complications or recovery time.

Treating spinal pain with replacement discs made of 'engineered living tissue' moves closer to reality

November 21, 2018
For the first time, bioengineered spinal discs were successfully implanted and provided long-term function in the largest animal model ever evaluated for tissue-engineered disc replacement. A new Penn Medicine study published ...

Screening for colorectal cancer spares male patients from intense treatments

November 21, 2018
While screening for colorectal cancer does not reduce mortality, it does reduce the need for chemotherapy and emergency surgeries among male patients, according to a recent Finnish study.

Rapid response inpatient education boosts use of needed blood-thinning drugs

November 16, 2018
A new study designed to reach hospitalized patients at risk shows that a "real-time" educational conversation, video or leaflet can lower the missed dose rates of drugs that can prevent potentially lethal blood clots in their ...

Race plays role in regaining weight after gastric bypass surgery

November 15, 2018
African Americans and Hispanic Americans who have undergone Roux-en-Y gastric bypass (RYGB) are at greater risk to regain weight as compared to Caucasians. To date, no study has addressed the effect of race on weight regain ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.